The TolllIL-l Receptor (TIR) domain is an essential signalling module in eukaryotic innate immune signalling pathways. Homotypic interaction between TIR domains allows the formation of a signalling platform in which molecules are able to interact and activate each other to initiate an immune signalling cascade. Proteins containing TIR domains have also been discovered in bacteria. Studies have subsequently shown that these proteins are able to modulate mammalian immune signalling pathways dependent on TIR interactions and that this forms an evasion strategy for bacterial pathogens. In this study a bioinformatic search for proteins containing TIR domains was carried out across unicellular organisms, including bacteria. TIR domain proteins (T...
Multicellular organisms constantly encounter microbes, ranging from beneficial to pathogenic. In ord...
Yersinia pestis, a Gram-negative bacterium and the etiologic agent of plague, has evolved from Yersi...
Sepsis is not only the leading cause of death in non-coronary intensive care units (ICUs) but also o...
The TolllIL-l Receptor (TIR) domain is an essential signalling module in eukaryotic innate immune si...
The TolllIL-l Receptor (TIR) domain is an essential signalling module in eukaryotic innate immune s...
The Toll/interleukin-1 receptor/resistance protein (TIR) domain is a protein-protein interaction dom...
The Toll/interleukin-1 receptor (TIR) domain plays a crucial role in the mammalian innate immune res...
The Toll/interleukin-1 receptor Stimulator of interferon genes (TIR-STING) domain plays a pivot role...
In mammals, Toll-like receptors (TLRs) recognize conserved microbial molecular signatures and induce...
Pathogenic microbes have evolved sophisticated molecular strategies to subvert host defenses. Here w...
Toll-like receptors (TLRs) recognise pathogenic microorganisms through conserved pathogen associated...
Toll-like receptor signaling, mediated by functional Toll/interleukin-1 receptor (TIR) domains, play...
Toll-like receptor signaling, mediated by functional Toll/interleukin-1 receptor (TIR) domains, play...
Staphylococcus aureus, sequence type (ST) 398, is an emerging pathogen and the leading cause of live...
Staphylococcus aureus, sequence type (ST) 398, is an emerging pathogen and the leading cause of live...
Multicellular organisms constantly encounter microbes, ranging from beneficial to pathogenic. In ord...
Yersinia pestis, a Gram-negative bacterium and the etiologic agent of plague, has evolved from Yersi...
Sepsis is not only the leading cause of death in non-coronary intensive care units (ICUs) but also o...
The TolllIL-l Receptor (TIR) domain is an essential signalling module in eukaryotic innate immune si...
The TolllIL-l Receptor (TIR) domain is an essential signalling module in eukaryotic innate immune s...
The Toll/interleukin-1 receptor/resistance protein (TIR) domain is a protein-protein interaction dom...
The Toll/interleukin-1 receptor (TIR) domain plays a crucial role in the mammalian innate immune res...
The Toll/interleukin-1 receptor Stimulator of interferon genes (TIR-STING) domain plays a pivot role...
In mammals, Toll-like receptors (TLRs) recognize conserved microbial molecular signatures and induce...
Pathogenic microbes have evolved sophisticated molecular strategies to subvert host defenses. Here w...
Toll-like receptors (TLRs) recognise pathogenic microorganisms through conserved pathogen associated...
Toll-like receptor signaling, mediated by functional Toll/interleukin-1 receptor (TIR) domains, play...
Toll-like receptor signaling, mediated by functional Toll/interleukin-1 receptor (TIR) domains, play...
Staphylococcus aureus, sequence type (ST) 398, is an emerging pathogen and the leading cause of live...
Staphylococcus aureus, sequence type (ST) 398, is an emerging pathogen and the leading cause of live...
Multicellular organisms constantly encounter microbes, ranging from beneficial to pathogenic. In ord...
Yersinia pestis, a Gram-negative bacterium and the etiologic agent of plague, has evolved from Yersi...
Sepsis is not only the leading cause of death in non-coronary intensive care units (ICUs) but also o...